MNST Stock Analysis: Monster Beverage | NASDAQ
Beverages - Non-Alcoholic | NASDAQ, USA | Market Cap: 95.454m USD | 12M Return: 64.6% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 548M
EPS Trend: 53.7%
Qual. Beats: 1
Rev. Trend: 94.8%
Qual. Beats: 3
Warnings
No concerns identified
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Monster Beverage Corporation (NASDAQ: MNST) develops, markets, sells, and distributes energy drinks and beverage concentrates through four reporting segments: Monster Energy Drinks, Strategic Brands, Alcohol Brands, and Other. Its product portfolio spans carbonated and non-carbonated energy drinks, iced teas, lemonades, juices, dairy and coffee drinks, sports drinks, still waters, and sodas, sold under a broad brand family that includes Monster Energy, Reign, NOS, Full Throttle, Bang Energy, and Mother, among others.
The company also markets craft beers, flavored malt beverages, and hard seltzers under brands such as Jai Alai IPA, Dales Pale Ale, and Wild Basin Hard Seltzers, reflecting its diversification beyond non-alcoholic energy drinks into the alcoholic beverage space. Its distribution network covers full-service bottlers, grocery and specialty chains, wholesalers, club and mass merchandisers, convenience and gas chains, food service operators, e-commerce retailers, and military channels, reaching both U.S. and international markets.
Monster Beverage operates primarily in the U.S. consumer staples soft drinks and non-alcoholic beverages sub-industry, where it competes in the high-growth energy drink category against peers such as Coca-Colas energy portfolio and Red Bull. Founded in 1985 and headquartered in Corona, California, the company was formerly known as Hansen Natural Corporation before adopting its current name in January 2012.
- Monster Energy Drinks segment volume growth drives core revenue
- Celsius competition pressures pricing and shelf space
- Coca-Cola bottler network accelerates international market expansion
| Net Income: 2.03b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.19 > 0.02 and ΔFCF/TA -2.58 > 1.0 |
| NWC/Revenue: 46.59% < 20% (prev 39.07%; Δ 7.52% < -1%) |
| CFO/TA 0.20 > 3% & CFO 2.20b > Net Income 2.03b |
| Net Debt (-2.95b) to EBITDA (2.78b): -1.06 < 3 |
| Current Ratio: 3.26 > 1.5 & < 3 |
| Outstanding Shares: last quarter (988.3m) vs 12m ago 0.71% < -2% |
| Gross Margin: 55.47% > 18% (prev 54.64%; Δ 0.83% > 0.5%) |
| Asset Turnover: 92.22% > 50% (prev 90.53%; Δ 1.68% > 0%) |
| Interest Coverage Ratio: 830.6 > 6 (EBIT TTM 2.66b / Interest Expense TTM 3.20m) |
| A: 0.38 (Total Current Assets 5.91b - Total Current Liabilities 1.82b) / Total Assets 10.8b |
| B: 0.92 (Retained Earnings 9.92b / Total Assets 10.8b) |
| C: 0.28 (EBIT TTM 2.66b / Avg Total Assets 9.54b) |
| D: 4.12 (Book Value of Equity 8.73b / Total Liabilities 2.12b) |
| Altman-Z'' = 11.66 = AAA |
| DSRI: 1.17 (Receivables 1.88b/1.36b, Revenue 8.79b/7.45b) |
| GMI: 0.99 (GM 54.64% / 55.47%) |
| AQI: 0.98 (AQ_t 0.36 / AQ_t-1 0.36) |
| SGI: 1.18 (Revenue 8.79b / 7.45b) |
| TATA: -0.02 (NI 2.03b - CFO 2.20b) / TA 10.8b) |
| Beneish M = -2.78 (Cap -4..+1) = A |
As of July 12, 2026, the stock is trading at USD 97.39 with a total of 3,463,631 shares traded. Over the past week, the price has changed by -0.22%, over one month by +6.78%, over three months by +28.62% and over the past year by +64.59%.
Current recommended Stop Loss: 92.90 (which is 4.6% or 2.2 ATR below the current price).
Monster Beverage has received a consensus analysts rating of 3.76. Therefore, it is recommended to hold MNST.
- StrongBuy: 10
- Buy: 3
- Hold: 9
- Sell: 2
- StrongSell: 1
| Analysts Target Price | 89.7 | -7.9% |
P/E Trailing = 47.1498
P/E Forward = 42.735
P/S = 10.8555
P/B = 10.9377
P/EG = 2.8349
Revenue TTM = 8.79b USD
EBIT TTM = 2.66b USD
EBITDA TTM = 2.78b USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 30.3m USD (Leases only: 30.3m)
Net Debt = -2.95b USD (calculated: Debt 30.3m - CCE 2.98b)
Enterprise Value = 92.5b USD (95.5b + Debt 30.3m - CCE 2.98b)
Interest Coverage Ratio = 830.6 (Ebit TTM 2.66b / Interest Expense TTM 3.20m)
EV/FCF = 44.65x (Enterprise Value 92.5b / FCF TTM 2.07b)
FCF Yield = 2.24% (FCF TTM 2.07b / Enterprise Value 92.5b)
FCF Margin = 23.56% (FCF TTM 2.07b / Revenue TTM 8.79b)
Net Margin = 23.11% (Net Income TTM 2.03b / Revenue TTM 8.79b)
Gross Margin = 55.47% ((Revenue TTM 8.79b - Cost of Revenue TTM 3.92b) / Revenue TTM)
Gross Margin QoQ = 54.96% (prev 55.53%)
Tobins Q-Ratio = 8.53 (Enterprise Value 92.5b / Total Assets 10.8b)
Interest Expense / Debt = 10.55% (Interest Expense 3.20m / Debt 30.3m)
Taxrate = 23.46% (622.7m / 2.65b)
NOPAT = 2.03b (EBIT 2.66b * (1 - 23.46%))
Current Ratio = 3.26 (Total Current Assets 5.91b / Total Current Liabilities 1.82b)
Debt / Equity = 0.00 (Debt 30.3m / totalStockholderEquity, last quarter 8.73b)
Debt / EBITDA = -1.06 (Net Debt -2.95b / EBITDA 2.78b)
Debt / FCF = -1.43 (Net Debt -2.95b / FCF TTM 2.07b)
Total Stockholder Equity = 7.98b (last 4 quarters mean from totalStockholderEquity)
RoA = 21.31% (Net Income 2.03b / Total Assets 10.8b)
RoE = 25.46% (Net Income TTM 2.03b / Total Stockholder Equity 7.98b)
RoCE = 29.44% (EBIT 2.66b / Capital Employed (Total Assets 10.8b - Current Liab 1.82b))
RoIC = 23.69% (NOPAT 2.03b / Invested Capital 8.59b)
WACC = 6.67% (E(95.5b)/V(95.5b) * Re(6.67%) + D(30.3m)/V(95.5b) * Rd(10.55%) * (1-Tc(0.23)))
Discount Rate = 6.67% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -15.56 | Cagr: -2.76%
[DCF] Terminal Value 77.97% ; FCFF base≈1.96b ; Y1≈2.24b ; Y5≈3.30b
[DCF] Fair Price = 53.81 (EV 49.7b - Net Debt -2.95b = Equity 52.6b / Shares 978.0m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 53.67 | EPS CAGR: 6.71% | SUE: 0.94 | # QB: 1
Revenue Correlation: 94.77 | Revenue CAGR: 8.23% | SUE: 2.35 | # QB: 3
EPS current Quarter (2026-06-30): EPS=0.58 | Chg30d=-0.16% | Revisions=+38% | Analysts=7
EPS next Quarter (2026-09-30): EPS=0.59 | Chg30d=+0.62% | Revisions=-44% | Analysts=7
EPS current Year (2026-12-31): EPS=2.26 | Chg30d=-0.30% | Revisions=+36% | GrowthEPS=+16.6% | GrowthRev=+15.2%
EPS next Year (2027-12-31): EPS=2.56 | Chg30d=+0.37% | Revisions=+70% | GrowthEPS=+13.0% | GrowthRev=+8.3%
[Analyst] Revisions Ratio: +34% (up=18, down=8)